Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Cannabis Taxation topic
No spam. Unsubscribe anytime.
Committee narrows cannabis tax proposal, removes medical‑sales change after industry concerns
Summary
Lawmakers discussed amendments to taxes on adult‑use cannabis including delaying excise payments, reclassifying pre‑roll material, and equalizing hemp product taxes. Industry and Office of Cannabis Policy raised implementation and market‑share concerns about letting medical patients buy at adult‑use stores at the lower tax rate; item was removed and the amended package was later tabled for more detail.
Committee members discussed a bundle of proposed changes to adult‑use cannabis taxation and administration under LD 19 42. The sponsor presented four amendment bullets: delay excise tax payment timing to match tobacco schedules, reclassify raw pre‑roll material from "bud" to "trim" for excise purposes, allow medical cardholders to purchase at adult‑use stores at the medical tax rate on proof of a medical card, and equalize tax treatment for intoxicating hemp products.
Retail and patient‑safety concerns dominated questioning. Hannah King of Cannabis Maine urged the panel to consider mandatory tracking and testing differences between adult‑use and medical programs and warned about the operational complexity if two tax rates applied to the same point‑of‑sale. "Right now in Maine, there is no mandatory testing or tracking of medical cannabis... we have mandatory tracking and testing in our adult use program," King said, arguing that the proposal would give medical patients the option to select tested and tracked product.
Office of Cannabis Policy Policy Director Gabrielle Barabie told the committee OCP can provide market‑share data and noted retailers already ring transactions as adult‑use or medical in many states; point‑of‑sale systems can support different tax treatments but availability varies by vendor.
After discussion and industry input, a motion to advance the amendment was revised to exclude the provision allowing medical purchases at adult‑use stores at the medical sales tax rate. Representative Crockett, who moved an "ought to pass as amended" motion, agreed to remove item (3) given the operational and market concerns. The committee ultimately tabled the bill to gather more detailed feedback from MRS, OCP and industry stakeholders.
What's next: staff will solicit more detailed input from OCP, industry point‑of‑sale vendors, and MRS on operational feasibility and expected revenue implications before reshaping the amendment or resuming consideration.
